SCHEMBL3757723

SCHEMBL3757723

CC1(C)Cc2c(sc(N3CCOCC3)c2-c2ccnc(-c3cccc(C(=O)CCl)c3)c2)C(=O)N1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 4/20 0.37
PIK3CD O00329 3/20 0.37
PIK3CB P42338 3/20 0.37
PIK3CG P48736 3/20 0.37
PLOD2 O00469 2/20 0.35
PLOD3 O60568 2/20 0.35
PLOD1 Q02809 2/20 0.35
KDM1A O60341 1/20 0.34
HDAC1 Q13547 1/20 0.34
JMJD6 Q6NYC1 1/20 0.34
ALDH1A1 P00352 3/20 0.34
PIK3R1 P27986 1/20 0.34
MTOR P42345 1/20 0.34
NPSR1 Q6W5P4 3/20 0.34
L3MBTL1 Q9Y468 3/20 0.34
SCN9A Q15858 1/20 0.33
JAK2 O60674 1/20 0.33
LMNA P02545 2/20 0.33
MEN1 O00255 1/20 0.33
CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3765967 0.92 PIK3CA (0.36) PIK3CAPIK3CDPIK3CBPIK3CGPLOD2
SCHEMBL3769336 0.91 PIK3CD (0.36) PIK3CAPIK3CDPIK3CBPIK3CGPLOD2
SCHEMBL3765884 0.91 PRKDC (0.41) PIK3CAPIK3CDPIK3CBPIK3CGKDM1A
SCHEMBL3760006 0.91 PRKDC (0.39) PIK3CAPIK3CDPIK3CBPIK3CGKDM1A
SCHEMBL3761312 0.89 LRRK2 (0.41) PIK3CAPIK3CDPIK3CBPIK3CGALDH1A1
SCHEMBL16161804 0.88 ATR (0.40) PIK3CAPIK3CDPIK3CBPIK3CGMTOR
SCHEMBL3760314 0.87 PIK3CD (0.42) PIK3CAPIK3CDPIK3CBPIK3CGALDH1A1
SCHEMBL3764670 0.87 PIK3CA (0.43) PIK3CAPIK3CDPIK3CBPIK3CGMTOR
SCHEMBL3762152 0.87 MTOR (0.38) PIK3CAPIK3CDPIK3CBPIK3CGMTOR
SCHEMBL3756048 0.87 KDM4E (0.38) PIK3CAPIK3CDPIK3CBPIK3CGALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA PIK3CA 3/4885PIK3CD 9/4885PIK3CB 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.